Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Maintains Sell Rating on Overvalued HR Block

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
SO stock news
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On February 7, 2024, George Kelly, an analyst at Goldman Sachs, expressed a pessimistic view on H&R Block (NYSE:HRB). Despite raising the price target from $34 to $38, Kelly maintained a “Sell” rating on the stock. This decision signifies Goldman Sachs’ belief that H&R Block is currently overvalued and might struggle to meet expectations in the coming days.

HRB Stock Shows Mixed Performance with Significant Drop in Share Price: Analysis and Insights

On February 7, 2024, HRB stock, the ticker symbol for H&R Block, showcased a mixed performance as it traded near the top of its 52-week range but experienced a significant drop in its share price. According to data sourced from CNN Money, HRB was trading above its 200-day simple moving average, indicating a positive trend in the stock’s price momentum.

The day’s trading session saw a notable price change for HRB shares, with a decrease of $3.03 since the market last closed. This represented a drop of 6.39% in the stock’s value.

The stock opened at $45.42, which was $1.92 lower than its previous closing price. This lower opening price may have contributed to the overall downward movement in HRB’s share value throughout the day.

Despite the drop in share price, it is worth noting that HRB was still trading near the top of its 52-week range. This indicates that the stock had been performing well in the past year, reaching higher price levels than it had previously.

Furthermore, the fact that HRB was trading above its 200-day simple moving average suggests that the stock had been on an upward trajectory in terms of its long-term price trend.

Investors and analysts would likely be monitoring HRB closely following the significant drop in share price on February 7, 2024. They would be interested in understanding the factors behind the decline and assessing whether it was a temporary setback or a sign of a more significant issue with the company.

It is important to note that stock prices can be influenced by various factors, including market conditions, company-specific news, and investor sentiment. Therefore, it is advisable for investors to conduct thorough research and analysis before making any investment decisions based on stock performance alone.

HRB Stock Performance: Mixed Figures in Financials Raise Concerns for Investors

HRB stock experienced mixed performances on February 7, 2024, as the company’s financials revealed contrasting figures. The data highlights the total revenue, net income, and earnings per share (EPS) for the past year and the first quarter of the year.

Starting with the total revenue, HRB reported $3.47 billion in total revenue over the past year, which remained flat compared to the previous year. However, there was a significant decrease of 82.19% in total revenue since the last quarter, dropping to $183.80 million.

Moving on to the net income, HRB recorded a net income of $551.43 million over the past year, which held flat compared to the previous year. However, the net income took a sharp decline of 153.86% since the last quarter, resulting in a negative net income of -$163.05 million.

Examining the earnings per share (EPS), HRB reported an EPS of $3.51 over the past year, indicating a 9.07% increase compared to the previous year. However, the EPS plummeted by 157.05% since the last quarter, reaching -$1.12.

Considering these financial figures, HRB stock performances on February 7, 2024, may be influenced by the contrasting trends. The flat total revenue and net income compared to the previous year could provide some stability to the stock, but the significant declines in both metrics since the last quarter may overshadow any positive sentiment.

Investors and analysts will closely monitor HRB’s ability to rebound from the negative net income and the subsequent impact on the EPS. Additionally, HRB’s future strategies and initiatives to address the decline in revenue will play a crucial role in determining the stock’s performance in the coming months.

It is important to note that stock performances are influenced by various factors, including market conditions, industry trends, and company-specific developments. Therefore, investors should conduct thorough research and analysis before making any investment decisions related to HRB stock.

Tags: HRB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Exchange

Evaxion Biotech AS Regains Compliance with Nasdaq Listing Rule 5550a2

Electronic and Electrical Equipment Markets and money

Herc Holdings Increases Quarterly Dividend by 5 to Reward Shareholders

Biotechnology Stock Market Today (1)

One Stop Systems Inc Ships Gen 5 4U Pro Accelerator System to Prominent Provider of Composable Infrastructure

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com